SEC Form 4 · accession 0001144204-18-046142
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack Bendheim
Officer — President and CEO · Director · 10% Owner
Period of report
Aug 21, 2018
Accepted (ET)
Aug 23, 2018 · 9:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1,F2,F3 | Aug 21, 2018 | C | 30,000 | $0.00 | A | 60,000 | I | See |
| Class A Common StockF2,F4,F3 | Aug 21, 2018 | S | 10,000 | $50.35 | D | 50,000 | I | See |
| Class A Common StockF2,F5,F3 | Aug 22, 2018 | S | 10,000 | $49.92 | D | 40,000 | I | See |
| Class A Common StockF2,F6,F3 | Aug 23, 2018 | S | 10,000 | $49.84 | D | 30,000 | I | See |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Class B Common StockF2,F3,F1 | $0.00 | Aug 21, 2018 | C | 30,000 | D | — | — | Class A Common Stock | 30,000 | 20,216,034 | I |
Explanation of responses
- F1Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017.
- F3The securities are held by BFI Co., LLC. Mr. Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFICo., LLC and may be deemed to have shared voting and investment power over the securities held by BFI Co., LLC. Mr. Bendheim disclaims beneficialownership of these securities except to the extent of his pecuniary interest therein.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.90 to $50.65, inclusive.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.75 to $50.65, inclusive.
- F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.70 to $50.10, inclusive.